Compare GLAD & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLAD | OFIX |
|---|---|---|
| Founded | 2001 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 429.7M | 481.0M |
| IPO Year | 2001 | 1998 |
| Metric | GLAD | OFIX |
|---|---|---|
| Price | $19.67 | $10.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $22.33 | $17.25 |
| AVG Volume (30 Days) | 165.1K | ★ 335.6K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 9.78% | N/A |
| EPS Growth | ★ 91.82 | 29.39 |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | $15.16 | $6.13 |
| Revenue Next Year | $5.10 | $6.22 |
| P/E Ratio | $19.73 | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $16.54 | $8.85 |
| 52 Week High | $26.49 | $16.99 |
| Indicator | GLAD | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 52.49 | 40.75 |
| Support Level | $18.52 | $8.99 |
| Resistance Level | $20.23 | $12.56 |
| Average True Range (ATR) | 0.41 | 0.54 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 65.73 | 7.59 |
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.